CompletedNot applicableNCT00148603
Montelukast in the Treatment of Duodenal Eosinophilia
Studying Eosinophilic gastroenteritis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Children's Mercy Hospital Kansas City
- Principal Investigator
- Craig A Friesen, M.DChildren's Mercy Hospital and Clinics
- Intervention
- montelukast(drug)
- Enrollment
- 24 enrolled
- Eligibility
- 8-17 years · All sexes
- Timeline
- 2005 – 2006
Study locations (1)
- Children's Mercy Hospital and Clinics, Kansas City, Missouri, United States
Collaborators
Merck Sharp & Dohme LLC
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00148603 on ClinicalTrials.govOther trials for Eosinophilic gastroenteritis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07506746PRospective Registry of Esophageal MotilityIRCCS San Raffaele
- ACTIVE NOT RECRUITINGPHASE2NCT05831176A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May HaveRegeneron Pharmaceuticals